Cinnamon extract
Metabolic health

Cinnamon extract

Cinnamon extracts (from Cinnamomum spp.) are used as supplements to support metabolic health, particularly for glycemic control. The effectiveness observed in studies varies depending on the species (e.g. C. cassia vs C. verum), the type of extract, polyphenol standardization, and the presence of coumarin, a compound potentially hepatotoxic at high doses or in predisposed individuals.

Phytocompound with evidence on blood glucose and insulin sensitivity, with critical issues related to standardization and coumarin content

Cinnamon (extract) and metabolic health

Cinnamon extracts (from Cinnamomum spp.) are used as supplements to support metabolic health, particularly for glycemic control. The efficacy observed in studies varies according to the species (e.g. C. cassia vs C. verum), the type of extract, the standardization of polyphenols, and the presence of coumarin, a compound that may be hepatotoxic at high doses or in predisposed individuals.

Mechanism of action

Proposed mechanisms (not all definitively confirmed in humans): (1) improvement of insulin signaling and glucose uptake (e.g. increased GLUT4 translocation in experimental models); (2) modulation of carbohydrate-digesting enzymes (partial inhibition of alpha-amylase and alpha-glucosidase), with a possible reduction in postprandial glycemic spikes; (3) antioxidant and anti-inflammatory effects mediated by polyphenols, with potential impact on oxidative stress and low-grade inflammation associated with insulin resistance; (4) possible modulation of the gut microbiota and circulating phenolic metabolites; (5) effects on lipid and adipocyte metabolism observed mainly in preclinical models. The clinical magnitude of these effects depends on dose, duration, population, and extract standardization.

Supported benefits

  • Modest reduction in fasting blood glucose in individuals with impaired glucose metabolism (e.g. prediabetes or type 2 diabetes) in some trials and meta-analyses (moderate)
  • Possible small improvement in HbA1c in some studies on type 2 diabetes, with heterogeneous results (limited)
  • Possible reduction in triglycerides and/or total/LDL cholesterol in some meta-analyses, with high variability between studies (limited)
  • Reduction in postprandial glycemic spikes when taken with carbohydrate-rich meals in some studies (emerging)

Safety & side effects

  • Gastrointestinal disturbances (nausea, dyspepsia, diarrhea), especially at higher doses
  • Oral or mucosal irritation (more common with powder; also possible with extracts)
  • Allergic reactions or contact dermatitis in sensitive individuals
  • Increased risk of hepatotoxicity in cases of high coumarin exposure (more relevant with Cassia cinnamon), especially in predisposed individuals or with prolonged use

FAQ

Are Ceylon cinnamon and Cassia equivalent in supplements?

No. They can differ greatly in coumarin content and phytochemical profile. Cassia tends to contain more coumarin, making safety considerations more important in cases of regular or high-dose use.

Does cinnamon “lower blood sugar” reliably?

Studies show, on average, small and variable effects, more evident in some populations with elevated blood glucose. The response depends on dose, duration, type of extract, and individual characteristics; it is not a substitute for therapies or lifestyle measures.

Is powder or extract better?

Extracts may offer greater standardization of bioactive compounds and, in some cases, control of coumarin content. However, variability between products remains high; powder may increase coumarin exposure if Cassia is used in significant amounts.

How long does it take to see effects in trials?

In trials, metabolic endpoints are often evaluated after 4–16 weeks. The effects, when present, tend to be gradual and not always clinically meaningful.

Are there markers to monitor if using a cinnamon extract?

In clinical settings, typical markers of metabolic health include blood glucose, HbA1c, and lipid profile; for safety, liver function monitoring may be considered in at-risk individuals. These assessments should be decided with a qualified healthcare professional.

The information provided is for informational and educational purposes only. It does not constitute medical advice. Use should be evaluated and authorized by a qualified healthcare professional.

Mechanism of action

Proposed mechanisms (not all definitively confirmed in humans): (1) improved insulin signaling and glucose uptake (e.g. increased GLUT4 translocation in experimental models); (2) modulation of carbohydrate-digesting enzymes (partial inhibition of alpha-amylase and alpha-glucosidase), with possible reduction of postprandial glycemic spikes; (3) antioxidant and anti-inflammatory effects mediated by polyphenols, with potential impact on oxidative stress and low-grade inflammation associated with insulin resistance; (4) possible modulation of the gut microbiota and circulating phenolic metabolites; (5) effects on lipid and adipocyte metabolism observed mainly in preclinical models. The clinical magnitude of these effects depends on dose, duration, population, and extract standardization.

Scientific benefits

Modest reduction in fasting blood glucose in subjects with altered glucose metabolism (e.g. prediabetes or type 2 diabetes) in some trials and meta-analyses
Evidence level: moderate
Possible small improvement in HbA1c in some studies on type 2 diabetes, with heterogeneous results
Evidence level: limited
Possible reduction in triglycerides and/or total/LDL cholesterol in some meta-analyses, with high variability between studies
Evidence level: limited
Reduction of postprandial glycemic spikes when taken with carbohydrate-rich meals in some studies
Evidence level: emerging

Contraindications

  • Active liver disease or history of unexplained liver damage (caution due to possible coumarin exposure)
  • Pregnancy and breastfeeding: insufficient data for concentrated extracts; caution
  • Known allergy to cinnamon or other components of the product
  • Bleeding disorders or anticoagulant/antiplatelet therapy: caution due to potential increased bleeding risk (and product variability)
  • Diabetes treated with medication: risk of hypoglycemia if combined with glucose-lowering drugs (clinical supervision required)

Side effects

  • Gastrointestinal disturbances (nausea, dyspepsia, diarrhea), especially at higher doses
  • Oral or mucosal irritation (more common with powder; also possible with extracts)
  • Allergic reactions or contact dermatitis in sensitive individuals
  • Increased risk of hepatotoxicity in case of high coumarin exposure (more relevant with Cassia cinnamon), especially in predisposed individuals or with prolonged use

Interactions

  • Glucose-lowering drugs (e.g. insulin, sulfonylureas, metformin, GLP-1 RA, SGLT2i): possible additive effect on glycemic reduction with risk of hypoglycemia in some individuals
  • Anticoagulants/antiplatelets (e.g. warfarin, DOACs, aspirin, clopidogrel): potential increased bleeding risk; moreover, coumarin is not equivalent to warfarin but may cause confusion and requires caution
  • Hepatotoxic drugs or excessive alcohol: possible increased burden on the liver, especially with coumarin-rich products
  • Substrates/inducers/inhibitors of hepatic enzymes (CYP): human data are inconclusive; caution due to individual and product variability

Regulatory status

In the EU and in many other regions, cinnamon is permitted as a food and as an ingredient in supplements; for coumarin there are indications/limits especially for flavored foods and recommendations to limit exposure. Health claims are regulated and often limited; product quality may vary (botanical species, coumarin, standardization).

Supplements and peptides

All supplements